Research and System Development on Functional 3D Optical Tomography for Skin Cell Imaging
1 other identifier
observational
30
0 countries
N/A
Brief Summary
The investigators will obtain human skin specimen (sized approximately 1 cm x 1 cm) for dermatological surgical patients in National Taiwan University Hospital, after informed consent was obtained. Human skin keratinocytes, fibroblasts, and melanocytes will be cultured from the human skin specimen. The three dimensional images of these cultured cells will be observed by a ultra-high resolution 3-dimensional optical coherence tomography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2012
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 15, 2012
CompletedFirst Posted
Study publicly available on registry
March 19, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedMarch 19, 2012
March 1, 2012
1.1 years
March 15, 2012
March 16, 2012
Conditions
Keywords
Eligibility Criteria
Aged between 20 to 100. People who received benign skin tumor removal in dermatological surgical unit. OR people who received skin grafts (full thickness or split thickness) for reconstruction of surgical wounds after removing malignant skin cancer.
You may qualify if:
- Aged between 20 to 100.
- People who received benign skin tumor removal in dermatological surgical unit. OR
- People who received skin grafts (full thickness or split thickness) for reconstruction of surgical wounds after removing malignant skin cancer.
You may not qualify if:
- Age less than 20 years old,
- Psychiatric patients,
- Pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
No biospecimen to be retained.
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 15, 2012
First Posted
March 19, 2012
Study Start
March 1, 2012
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
March 19, 2012
Record last verified: 2012-03